Exact Mass: 468.0256

Exact Mass Matches: 468.0256

Found 59 metabolites which its exact mass value is equals to given mass value 468.0256, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cromoglicic acid

5-{3-[(2-carboxy-4-oxo-4H-chromen-5-yl)oxy]-2-hydroxypropoxy}-4-oxo-4H-chromene-2-carboxylic acid

C23H16O11 (468.0693)


Cromoglicic acid is only found in individuals that have used or taken this drug. It is a chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. [PubChem]Cromoglicate inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. Cromoglicate also may reduce the release of inflammatory leukotrienes. Cromoglicate may act by inhibiting calcium influx. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07E - Intestinal antiinflammatory agents > A07EB - Antiallergic agents, excl. corticosteroids R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AH - Agents for dermatitis, excluding corticosteroids C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C29714 - Mast Cell Stabilizer S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics D000893 - Anti-Inflammatory Agents > D000082142 - Mast Cell Stabilizers D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D018926 - Anti-Allergic Agents D007155 - Immunologic Factors

   

C.I. Pigment Yellow 100

5-Hydroxy-1-(4-sulphophenyl)-4-[(e)-2-(4-sulphophenyl)diazen-1-yl]-1H-pyrazole-3-carboxylic acid

C16H12N4O9S2 (468.0046)


FDA permitted colourant for food and food contact paper or board. FDA permitted colourant for food and food contact paper or board

   

Primisulfuron-methyl

methyl 2-[({[4,6-bis(difluoromethoxy)pyrimidin-2-yl]carbamoyl}amino)sulfonyl]benzoate

C15H12F4N4O7S (468.0363)


   

5-[(2R)-3-(2-Carboxy-4-oxochromen-6-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylic acid

5-{3-[(2-carboxy-4-oxo-4H-chromen-6-yl)oxy]-2-hydroxypropoxy}-4-oxo-4H-chromene-2-carboxylic acid

C23H16O11 (468.0693)


   
   
   

2-[(4-Chlorobenzyl)sulfonyl]-3-[3,5-bis(trifluoromethyl)anilino]acrylonitrile

2-[(4-Chlorobenzyl)sulfonyl]-3-[3,5-bis(trifluoromethyl)anilino]acrylonitrile

C18H11ClF6N2O2S (468.0134)


   
   
   

2-(a-Hydroxyethyl)thiamine diphosphate

2-(a-Hydroxyethyl)thiamine diphosphate

C14H22N4O8P2S (468.0634)


   
   

4, 19-Dibromo-3-ethyl-2, 20-dioxabicyclo[14.3.1]eicosa-1(19), 6, 9, 16-tetraen-12-yn-18-one, 9CI

4, 19-Dibromo-3-ethyl-2, 20-dioxabicyclo[14.3.1]eicosa-1(19), 6, 9, 16-tetraen-12-yn-18-one, 9CI

C20H22Br2O3 (467.9936)


   

Sanguisobic acid dilactone

Sanguisobic acid dilactone

C22H12O12 (468.0329)


   

Grape seed extract

Grape seed extract

C30H12O6 (468.0634)


   

cromolyn

Cromoglicic acid

C23H16O11 (468.0693)


A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07E - Intestinal antiinflammatory agents > A07EB - Antiallergic agents, excl. corticosteroids R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AH - Agents for dermatitis, excluding corticosteroids C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C29714 - Mast Cell Stabilizer S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics D000893 - Anti-Inflammatory Agents > D000082142 - Mast Cell Stabilizers D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D018926 - Anti-Allergic Agents D007155 - Immunologic Factors

   

Thiazolium

3-[(4-amino-2-Methyl-5-pyrimidinyl)methyl]-2-(1-hydroxyethyl)-4-methyl-5-(4,6,6-trihydroxy-3,5-dioxa-4,6-diphosphahex-1-yl)- P,p-dioxide

C14H22N4O8P2S (468.0634)


   

1H,1H,2H,2H-PERFLUOROOCTYLTRIMETHOXYSILANE

1H,1H,2H,2H-PERFLUOROOCTYLTRIMETHOXYSILANE

C11H13F13O3Si (468.0426)


   

Dibrompropamidine

Dibrompropamidine

C17H18Br2N4O2 (467.9796)


D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AC - Biguanides and amidines S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents

   

6-iodo-N-(3-Methyl-4-((6-Methylpyridin-3-yl)oxy)phenyl)quinazolin-4-amine

6-iodo-N-(3-Methyl-4-((6-Methylpyridin-3-yl)oxy)phenyl)quinazolin-4-amine

C21H17IN4O (468.0447)


   

ETHYLENE GLYCOL-BIS(BETA-AMINOETHYL ETHER)-N,N,N,N-TETRAACETIC ACID TETRASODIUM SALT

ETHYLENE GLYCOL-BIS(BETA-AMINOETHYL ETHER)-N,N,N,N-TETRAACETIC ACID TETRASODIUM SALT

C14H20N2Na4O10 (468.0709)


   

dimethyl perfluoroazelate

dimethyl perfluoroazelate

C11H6F14O4 (468.0043)


   

Sodium Hydrogen Ferric Dtpa

Sodium Hydrogen Ferric Dtpa

C14H19FeN3NaO10 (468.0317)


   

EUROPIUM(III) ACETYLACETONATE HYDRATE

EUROPIUM(III) ACETYLACETONATE HYDRATE

C15H23EuO7 (468.0656)


   

Benzenesulfonic acid,2-[(2,7-dihydro-3-methyl-2,7-dioxo-3H-naphtho[1,2,3-de]quinolin-6-yl)amino]-5-methyl-,sodium salt (1:1)

Benzenesulfonic acid,2-[(2,7-dihydro-3-methyl-2,7-dioxo-3H-naphtho[1,2,3-de]quinolin-6-yl)amino]-5-methyl-,sodium salt (1:1)

C24H17N2NaO5S (468.0756)


   

2-(perfluoro-5-methylhexyl)ethyl acrylate

2-(perfluoro-5-methylhexyl)ethyl acrylate

C12H7F15O2 (468.0207)


   

Bis(1,5-cyclooctadiene)rhodiuM(I) trifluoroMethanesulfonate

Bis(1,5-cyclooctadiene)rhodiuM(I) trifluoroMethanesulfonate

C17H24F3O3RhS (468.0453)


   

2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane

2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane

C12H21F9O3Si3 (468.0655)


   

2,2-[[2,2-bis(chloromethyl)propane-1,3-diyl]bis(oxy)]bis[5,5-dimethyl-1,3,2-dioxaphosphorinane] 2,2-dioxide

2,2-[[2,2-bis(chloromethyl)propane-1,3-diyl]bis(oxy)]bis[5,5-dimethyl-1,3,2-dioxaphosphorinane] 2,2-dioxide

C15H28Cl2O8P2 (468.0636)


   

1h,1h-perfluorooctyl methacrylate

1h,1h-perfluorooctyl methacrylate

C12H7F15O2 (468.0207)


   

adamexine

adamexine

C20H26Br2N2O (468.0412)


C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent

   

(2S,5R,6R)-6-({[1-(2,6-Dichlorophenyl)-4-methyl-1H-pyrazol-5-yl]c arbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hepta ne-2-carboxylic acid

(2S,5R,6R)-6-({[1-(2,6-Dichlorophenyl)-4-methyl-1H-pyrazol-5-yl]c arbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hepta ne-2-carboxylic acid

C19H18Cl2N4O4S (468.0426)


   
   

4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-2-pyridinecarboxamide

4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-2-pyridinecarboxamide

C20H13ClF4N4O3 (468.0612)


   

Poly[trifluoropropyl(methyl)siloxane]

Poly[trifluoropropyl(methyl)siloxane]

C12H21F9O3Si3 (468.0655)


   

3-[3,3,4,4,5,5-hexafluoro-2-(2-methyl-1-benzothiophen-3-yl)cyclopenten-1-yl]-2-methyl-1-benzothiophene

3-[3,3,4,4,5,5-hexafluoro-2-(2-methyl-1-benzothiophen-3-yl)cyclopenten-1-yl]-2-methyl-1-benzothiophene

C23H14F6S2 (468.0441)


   

FD&C Yellow No. 5 free acid

FD&C Yellow No. 5 free acid

C16H12N4O9S2 (468.0046)


   
   

2-Hydroxyethyl dihydrothiachrome diphosphate

2-Hydroxyethyl dihydrothiachrome diphosphate

C14H22N4O8P2S (468.0634)


   

5-[(2R)-3-(2-Carboxy-4-oxochromen-6-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylic acid

5-{3-[(2-carboxy-4-oxo-4H-chromen-6-yl)oxy]-2-hydroxypropoxy}-4-oxo-4H-chromene-2-carboxylic acid

C23H16O11 (468.0693)


   

3,4-bis(7-chloro-1H-indol-3-yl)-2,5-diiminohexanedioate

3,4-bis(7-chloro-1H-indol-3-yl)-2,5-diiminohexanedioate

C22H14Cl2N4O4-2 (468.0392)


   

[3-[[2-(Carboxymethoxy)benzoyl]amino]-2-methoxypropyl]mercury

[3-[[2-(Carboxymethoxy)benzoyl]amino]-2-methoxypropyl]mercury

C13H16HgNO5 (468.0735)


   

(2S,5S,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

(2S,5S,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C19H16Cl2N3O5S- (468.0188)


   

Dicloxacillin(1-)

Dicloxacillin(1-)

C19H16Cl2N3O5S- (468.0188)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

4-(Trifluoromethyl)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

4-(Trifluoromethyl)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C24H15F3N2O3S (468.0755)


   

N-(5-bromo-2-methoxybenzylidene)-5-[(2,3-dihydro-1H-inden-5-yloxy)methyl]-2-furohydrazide

N-(5-bromo-2-methoxybenzylidene)-5-[(2,3-dihydro-1H-inden-5-yloxy)methyl]-2-furohydrazide

C23H21BrN2O4 (468.0685)


   

3-chloro-N-[3-[[(3-chloro-4-nitrophenyl)-oxomethyl]amino]-2,2-dimethylpropyl]-4-nitrobenzamide

3-chloro-N-[3-[[(3-chloro-4-nitrophenyl)-oxomethyl]amino]-2,2-dimethylpropyl]-4-nitrobenzamide

C19H18Cl2N4O6 (468.0603)


   

3-(Trifluoromethyl)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

3-(Trifluoromethyl)benzoic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C24H15F3N2O3S (468.0755)


   

1-[(7-Chloro-4-oxo-2-pyrido[1,2-a]pyrimidinyl)methyl]-3-(3-fluoro-4-methylphenyl)thieno[3,2-d]pyrimidine-2,4-dione

1-[(7-Chloro-4-oxo-2-pyrido[1,2-a]pyrimidinyl)methyl]-3-(3-fluoro-4-methylphenyl)thieno[3,2-d]pyrimidine-2,4-dione

C22H14ClFN4O3S (468.0459)


   
   

2-fluorobenzoyl-AMP

2-fluorobenzoyl-AMP

C17H16FN5O8P- (468.072)


   

3-fluorobenzoyl-AMP

3-fluorobenzoyl-AMP

C17H16FN5O8P- (468.072)


   

4-fluorobenzoyl-AMP

4-fluorobenzoyl-AMP

C17H16FN5O8P- (468.072)


   

n-(2-{5-bromo-16-hydroxy-18-thia-2,12,15-triazapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-1(20),3,5,7,9(21),10,12,14(19),15-nonaen-20-yl}ethyl)ethanimidic acid

n-(2-{5-bromo-16-hydroxy-18-thia-2,12,15-triazapentacyclo[11.7.1.0³,⁸.0⁹,²¹.0¹⁴,¹⁹]henicosa-1(20),3,5,7,9(21),10,12,14(19),15-nonaen-20-yl}ethyl)ethanimidic acid

C21H17BrN4O2S (468.0256)


   

8-hydroxy-7-methyl-6-oxo-3-(prop-1-en-1-yl)-8,8a-dihydro-1h-isochromen-7-yl 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate

8-hydroxy-7-methyl-6-oxo-3-(prop-1-en-1-yl)-8,8a-dihydro-1h-isochromen-7-yl 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate

C22H22Cl2O7 (468.0743)


   

16-chloro-4,10-dihydroxy-6,15-dimethoxy-6,17-dimethyl-7-oxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-1(21),3,5(9),10,13,15,17,19-octaene-2,8,12-trione

16-chloro-4,10-dihydroxy-6,15-dimethoxy-6,17-dimethyl-7-oxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-1(21),3,5(9),10,13,15,17,19-octaene-2,8,12-trione

C24H17ClO8 (468.0612)


   

(7r,8s,8as)-8-hydroxy-7-methyl-6-oxo-3-[(1e)-prop-1-en-1-yl]-8,8a-dihydro-1h-isochromen-7-yl 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate

(7r,8s,8as)-8-hydroxy-7-methyl-6-oxo-3-[(1e)-prop-1-en-1-yl]-8,8a-dihydro-1h-isochromen-7-yl 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate

C22H22Cl2O7 (468.0743)


   

4,19-dibromo-3-ethyl-2,20-dioxabicyclo[14.3.1]icosa-1(19),6,9,16-tetraen-12-yn-18-one

4,19-dibromo-3-ethyl-2,20-dioxabicyclo[14.3.1]icosa-1(19),6,9,16-tetraen-12-yn-18-one

C20H22Br2O3 (467.9936)


   

(3s,4r,6e,9z)-4,19-dibromo-3-ethyl-2,20-dioxabicyclo[14.3.1]icosa-1(19),6,9,16-tetraen-12-yn-18-one

(3s,4r,6e,9z)-4,19-dibromo-3-ethyl-2,20-dioxabicyclo[14.3.1]icosa-1(19),6,9,16-tetraen-12-yn-18-one

C20H22Br2O3 (467.9936)